Info@ThinkPinkRocks.com

New England Journal of Medicine Case Study Reveals New Information about Advanced Melanoma Treatment

Add a Comment By Memorial Sloan-Kettering   |  Friday, December 7, 2012 Memorial Sloan-Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma. read more

View original post here:
New England Journal of Medicine Case Study Reveals New Information about Advanced Melanoma Treatment

Share

Leave a Reply